FGEN

FibroGen, Inc - Common Stock (FGEN)

About FibroGen, Inc - Common Stock (FGEN)

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.

Details

Daily high

$0.28

Daily low

$0.26

Price at open

$0.27

52 Week High

$1.53

52 Week Low

$0.18

Market cap

26.7M

Dividend yield

0.00%

Volume

364,939

Avg. volume

922,481

P/E ratio

-2.60

FibroGen, Inc - Common Stock News